DIFFUSION PHARMACEUTICALS
Dead / Abandoned — Abandoned — failure to respond (as of 01 Jul 2024)
What this means for you
This application is over — abandoned 10 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97510272
- Mark type
- Stylized text
- Filed
- 19 Jul 2022
- Abandoned
- 10 Jun 2024
- Attorney of record
- Marya K. Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tisue oxygenation that enhance performance of mammals
Owner
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
Prosecution history
- 01 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 07 Mar 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 07 Mar 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Dec 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Dec 2023 — FINAL REFUSAL E-MAILED
- 08 Dec 2023 — FINAL REFUSAL WRITTEN
- 10 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Aug 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Aug 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 09 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 May 2023 — NON-FINAL ACTION E-MAILED
- 09 May 2023 — NON-FINAL ACTION WRITTEN